Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 486
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
Higher mortgage rates don't just keep buyers on the sidelines. Application denials rise too
CrowdStrike is a buy, just not yet. Here's why
The Chase Sapphire Reserve's all-time-high 150,000-point bonus is ending soon. Here's why I applied
Eli Manning's private equity firm acquires licensing company for NFL Flag in bet on youth sports
Barclays traders say it's time to buy protection for a tech-led S&P 500 pullback
Interesting Quiet/Lesser Known Places To Go In Europe
Micron, Marvell, and Broadcom sink, leading chip stocks lower
Investors can 'buy' SpaceX early with Coinbase perpetual futures on pre-IPOs
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
SpaceX IPO hype has traders flocking to this mid-cap stock